Meet our Judges

Meet the Innovation Award Judges

the competition Secretary

Mr. Ken Shaked,
Shaked & Co, Law Offices, Israel

Mr. Ken Shaked is the founder of Shaked & Co, Law Offices.
Mr. Shaked advises regularly his clients in all legal aspects of operations of high tech and life sciences companies, including licensing and sale of technology, joint ventures and commercial transactions.
Mr. Shaked received his LL.B from Tel Aviv University in 1988 and his MBA in 2004 from Haifa University.
Mr. Shaked accompanied activity of commercial entities from both the business and legal aspects for more than 20 years.
Mr. Shaked worked as a lawyer at leading offices and as corporate counsel of leading companies such as EL AL and Dexxon Pharmaceutical company.
Mr. Shaked managed startup companies as a VP portfolio companies of the Hebrew University and as a CEO of startup companies in clean-tech, biotech, and medical device.


Among Our Judges

David Bassa,
Stero Biotechs, Talent Biotechs (ex), XTL, Sela Group

  • CEO and owner of Sela Group, a formerly traded high-tech software house with over 300 workers and 800 high tech clients.
  • Talent biotechs main shareholder (ex) – CBD for GVHD - The first Cannabis exit in Israel by selling Talent biotechs to Kalytera
  • One of the shareholders  of XTL at Nasdaq
  • Stero main shareholder - A Cannabis based startup researching CBD and Steroids synergism.  
  • Main Shareholder of additional 5 start ups in biotech or high technologies.
  • Bassa has twice won Excellence awards from the president of Israel, in 1981 and 2002.
  

David Spitz,
Hi-end medical cannabis grower in Colorado, USA

Mr. Spitz’s has 30 years’ experience in creating, enhancing and extracting value for shareholders from companies.
Since 1979, Mr. Spitz has led several Israeli hi-tech companies to tremendous international success. From an early startup phase, to successful IPOs and numerous exits , establishing a strong international presence , and multiple strategic mergers and acquisitions in the US.
After exiting his company in 2001, Mr. Spitz has harnessed his vast operational and entrepreneurial experience and financial engineering to build a local investment bank in Denver, focusing on M&A and capital raises primarily in healthcare, behavioral health and drug rehab, as well as medical devices.
Recognizing the rare opportunity in real estate in 2009 with the US housing crisis, Mr. Spitz has successfully built a successful real estate business, when in 2014, Mr. Spitz has identified a new unique and rare opportunity in the new emerging Marijuana market in Denver. Mr. Spitz, again, capitalized on the opportunity and has taken Kind Love, a then failing hi-end medical marijuana company in Colorado, to a tremendous success, turning it around in a record time from survival to thrival, and propelling it to one of the most successful medical and recreational marijuana companies in Colorado, with one of the largest a state-of-the-art grows producing award-winning strains, hi-end recreational and medical retail centers, and a successful MIP (Marijuana Infused Products) processing plant, extracting cannabis oils and manufacturing a wide variety of products ranging from smokables ( Hash, shatter, solvent less , live resin and rosin, oils and tinctures, Etc.), to a wide array of eatables (Including baked goods, candy, chocolate, drinks Etc.) and a range of topical products (Such as: creams, lotions, oil, Etc.). In addition, Mr. Spitz is involved with several technologies and IP in the cannabis growing, processing, consumption, data and software in the cannabis field.
The key to Mr. Spitz’s success is the combination of strong entrepreneurial, business and leadership skills coupled with a vast strategic deal experience, an in-depth product and markets knowledge , and a vast international sales and marketing experience.

Ascher Shmulewitz
Chairman, Therapix Biosciences, Israel

Dr. Shmulewitz has more than twenty years of experience as a Life Science scientist, originator, executive, in management, operations, and finance with track record generating high multiple growth of BioPharmaceutical public and private companies in the US, Europe, and Israel. He has proven success in start-ups, turnarounds, and healthcare management, corporate and product development (in the US, Europe, and Israel as well). Dr. Shmulewitz combines extensive experience in R&D, operations, marketing, and Business Development, with start-ups and public companies.

Meir Koren